Kaempferitrin Attenuates Lipopolysaccharide‐Induced Cardiac Dysfunction Through Suppression of the NF‐κB/NLRP3 Signaling Pathway

Key Points

Cardiac dysfunction improves significantly with kaempferitrin treatment, enhancing heart function.
The study observed a reduction in left ventricular remodeling, indicating improved cardiac health.

Structured PICO

Population

LPS-induced cardiac dysfunction model

Intervention

Kaempferitrin (Kae)

Outcome

Left ventricular remodeling and cardiac dysfunctionsurrogate

Kaempferitrin demonstrates cardioprotective effects against LPS-induced cardiac dysfunction in a preclinical model by targeting the NF-κB/NLRP3/pyroptosis pathway.

Abstract

This study confirms that Kae alleviates LPS-induced left ventricular remodeling and cardiac dysfunction by suppressing the NF-κB/NLRP3/pyroptosis pathway.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Kuang et al. (Thu,) studied this question.

synapsesocial.com/papers/69a75b7fc6e9836116a22ee9 https://doi.org/https://doi.org/10.1002/iid3.70323

Bookmark

View Full Paper